In human glioma tissue, C18-ceramide levels are lower than in control tissue, and overexpression of CerS1 or exogenous C18-ceramide triggers ER stress, lethal autophagy, and cell death in glioma cell lines [147]. Here, CERS1 is linked to central nervous system cancer.